On june9,2012, President Xie of the company participated in the nationalThe 2012 Symposium on safety evaluation and quality control of traditional Chinese medicine injections was held to discuss relevant academic issues with colleagues in the industry.

Beijing, June 12 (Guoping)     The 2012 National Symposium on safety evaluation and quality control of traditional Chinese medicine injections, sponsored by the Chinese society of traditional Chinese medicine and co organized by Shenwei Pharmaceutical Group, was held in Beijing from June 8 to 10. The participating experts made wonderful speeches on the safety evaluation, industrial development and hot issues of traditional Chinese medicine injections.

Seminar site

At the seminar, the leaders and relevant experts had a full and in-depth discussion on the stabilization of traditional Chinese medicine injection policy, safety research, improvement of quality standards, industrial development and other aspects according to the actual situation of the listed traditional Chinese medicine injection. The participants agreed that traditional Chinese medicine injections are an important part of traditional Chinese medicine culture. In the outline of the 12th Five Year Plan, the state proposed to comprehensively improve the national drug standards and carry out the project of adverse reaction monitoring and safety re evaluation after drug marketing, which reflects the state's attention to the quality control of traditional Chinese medicine injections, and also shows the particularity and urgency of carrying out the safety re evaluation of traditional Chinese medicine injections; From the perspective of the overall pharmaceutical industry, the current situation of the varieties of traditional Chinese medicine injections does not meet the increasing drug safety requirements of the broad masses of the people. Therefore, it is necessary to conduct a comprehensive evaluation of traditional Chinese medicine injections to promote the healthy development of traditional Chinese medicine injections.

Chenzhong, vice president of Shenwei Pharmaceutical Group, made a thematic report entitled "strengthening the risk control of traditional Chinese medicine injection and ensuring the safety of people's medication" at the seminar. It also introduced in detail Shenwei pharmaceutical's efforts in the safe use of traditional Chinese medicine injections, the improvement of quality standards and inspection methods, and the application of high and new technologies in the production of traditional Chinese medicine injections. Chen Zhong introduced that as a leading enterprise occupying 70% of the market share of traditional Chinese medicine injections, Shenwei pharmaceutical actively responded to the call of the state, cooperated with domestic well-known pharmaceutical institutions and experts to formulate a sound plan, and re evaluated the listing safety of all 13 existing varieties of traditional Chinese medicine injections. At present, the post marketing safety re evaluation of Shenmai injection and Qingkailing injection has achieved good results.

For the post marketing re evaluation of traditional Chinese medicine injections, representative hospitals, class II or class III hospitals, with a large amount of investment, have been selected. Taking Shenmai injection as an example, 15000 cases have been done by June, excluding some training costs. The direct investment will be nearly 5million yuan, and 15000 more cases will be done. The total re evaluation cost of a variety will reach 12million yuan. "Although the investment is large, Shenwei must do a good job," Chen said.

Traditional Chinese medicine injections are an important part of traditional Chinese medicine culture. In the outline of the 12th Five Year Plan, the state proposed to comprehensively improve the national drug standards and carry out the project of adverse reaction monitoring and safety re evaluation after drug marketing, which reflects the state's attention to the quality control of traditional Chinese medicine injections, and also shows the importance and urgency of carrying out the safety re evaluation of traditional Chinese medicine injections; From the perspective of the overall pharmaceutical industry, the current situation of the varieties of traditional Chinese medicine injections does not adapt to the increasing drug safety requirements of the people, which requires a comprehensive evaluation of traditional Chinese medicine injections to promote the healthy development of traditional Chinese medicine injections.

This seminar will further help Chinese pharmaceutical enterprises to correctly and comprehensively understand and evaluate traditional Chinese medicine injections, improve the safety and effectiveness of products, and play a positive role in promoting the quality of traditional Chinese medicine injections, ensuring the safety of patients, promoting the culture of traditional Chinese medicine, and promoting the sustainable and healthy development of traditional Chinese medicine.